))
Lung Cancer Edition: Top Headlines for Week of January 15, 2024
Manage episode 407442247 series 3560281
Content provided by Healio. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Healio or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In this edition, FDA places hold on cell therapy trial after patient death, selpercatinib delivers superior outcomes and more. Read the full coverage here:
FDA places hold on trial of cell therapy for lung cancer after patient death
Selpercatinib delivers superior outcomes, may ‘reduce the burden of NSCLC’
First-line immunotherapy benefits patients of all races with NSCLC equally
Never-smoker lung cancer survivors require targeted surveillance
Cemiplimab plus chemotherapy improves outcomes in metastatic NSCLC
References:
Baramidze A, et al. Abstract 1495P. Presented at: European Society for Medical Oncology Congress; Oct. 20-24, 2023; Madrid.
Choi E, et al. JAMA Netw. Open. 2023;doi:10.1001/jamanetworkopen.2023.43278.
Lee M, et al. J. Natl Compr Canc Netw. 2023;doi:10.6004/jnccn.2023.7064
Zhou C, et al. N Engl J Med. 2023;doi:10.1056.NEJMoa2309457.
108 episodes
Share
